Literature DB >> 24083998

Cytomegalovirus seropositivity and serointensity are associated with hippocampal volume and verbal memory in schizophrenia and bipolar disorder.

J Houenou1, M-A d'Albis, C Daban, N Hamdani, M Delavest, J P Lepine, F-E Vederine, S Carde, M Lajnef, C Cabon, F Dickerson, R H Yolken, R Tamouza, C Poupon, M Leboyer.   

Abstract

INTRODUCTION: Cytomegalovirus (CMV) is a member of the herpesviridae family that has a limbic and temporal gray matter tropism. It is usually latent in humans but has been associated with schizophrenia, bipolar disorder and cognitive deficits in some populations. Hippocampal decreased volume and dysfunction play a critical role in these cognitive deficits. We hypothesized that CMV seropositivity and serointensity would be associated with hippocampal volume and cognitive functioning in patients with schizophrenia or bipolar disorder.
METHODS: 102 healthy controls, 118 patients with bipolar disorder and 69 patients with schizophrenia performed the California Verbal Learning Test (CVLT) and had blood samples drawn to assess CMV IgG levels. A subgroup of 52 healthy controls, 31 patients with bipolar disorder and 27 patients with schizophrenia underwent T1 MRI for hippocampal volumetry. We analyzed the association between CMV serointensity and seropositivity with hippocampal volume. We also explored the correlation between CMV serointensity and seropositivity and CVLT scores.
RESULTS: In both patient groups but not in controls, higher CMV serointensity was significantly associated with smaller right hippocampal volume. Further, in the group of patients with schizophrenia but not bipolar disorder, CMV serointensity was negatively correlated with CVLT scores.
CONCLUSION: CMV IgG titers are associated with decreased hippocampal volume and poorer episodic verbal memory in patients with schizophrenia or bipolar disorder. The mechanism of this association warrants further exploration.
© 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BD; Bipolar disorder; CMV; CVLT; CVLT Recall score for list A; CVLT-RC-A; California Verbal Learning Test; Cytomegalovirus; HC; Hippocampus; MADRS; Montgomery–Asberg Depression Scale; PANSS; Positive and Negative Syndrome Scale; Schizophrenia; Verbal memory; YMRS; Young Mania Rating Scale; bipolar disorder; cytomegalovirus; healthy controls

Mesh:

Substances:

Year:  2013        PMID: 24083998     DOI: 10.1016/j.pnpbp.2013.09.003

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  13 in total

Review 1.  Inflammation in Mental Disorders: Is the Microbiota the Missing Link?

Authors:  Sophie Ouabbou; Ying He; Keith Butler; Ming Tsuang
Journal:  Neurosci Bull       Date:  2020-06-27       Impact factor: 5.203

2.  GWAS, cytomegalovirus infection, and schizophrenia.

Authors:  Jakob Grove; Anders D Børglum; Brad D Pearce
Journal:  Curr Behav Neurosci Rep       Date:  2014-12-01

3.  An Early Developmental Marker of Deficit versus Nondeficit Schizophrenia.

Authors:  Brian Kirkpatrick; Özlem Gürbüz Oflezer; Mehtap Delice Arslan; Gary Hack; Emilio Fernandez-Egea
Journal:  Schizophr Bull       Date:  2019-10-24       Impact factor: 9.306

4.  Association of Cytomegalovirus and Toxoplasma gondii Antibody Titers With Bipolar Disorder.

Authors:  Mark A Frye; Brandon J Coombes; Susan L McElroy; Lori Jones-Brando; David J Bond; Marin Veldic; Francisco Romo-Nava; William V Bobo; Balwinder Singh; Colin Colby; Michelle K Skime; Joanna M Biernacka; Robert Yolken
Journal:  JAMA Psychiatry       Date:  2019-12-01       Impact factor: 21.596

Review 5.  The microbiome, immunity, and schizophrenia and bipolar disorder.

Authors:  Faith Dickerson; Emily Severance; Robert Yolken
Journal:  Brain Behav Immun       Date:  2016-12-18       Impact factor: 7.217

6.  Reduced Hippocampal Volume and Its Relationship With Verbal Memory and Negative Symptoms in Treatment-Naive First-Episode Adolescent-Onset Schizophrenia.

Authors:  Xujun Duan; Changchun He; Jianjun Ou; Runshi Wang; Jinming Xiao; Lei Li; Renrong Wu; Yan Zhang; Jingping Zhao; Huafu Chen
Journal:  Schizophr Bull       Date:  2021-01-23       Impact factor: 9.306

7.  Replicable association between human cytomegalovirus infection and reduced white matter fractional anisotropy in major depressive disorder.

Authors:  Haixia Zheng; Maurizio Bergamino; Bart N Ford; Rayus Kuplicki; Fang-Cheng Yeh; Jerzy Bodurka; Kaiping Burrows; Peter W Hunt; T Kent Teague; Michael R Irwin; Robert H Yolken; Martin P Paulus; Jonathan Savitz
Journal:  Neuropsychopharmacology       Date:  2021-01-26       Impact factor: 7.853

Review 8.  Antibodies in the Diagnosis, Prognosis, and Prediction of Psychotic Disorders.

Authors:  Thomas A Pollak; Jonathan P Rogers; Robert G Nagele; Mark Peakman; James M Stone; Anthony S David; Philip McGuire
Journal:  Schizophr Bull       Date:  2019-01-01       Impact factor: 9.306

9.  Congenital human cytomegalovirus infection and neurologic diseases in newborns.

Authors:  Xin-Yan Zhang; Feng Fang
Journal:  Chin Med J (Engl)       Date:  2019-09-05       Impact factor: 2.628

Review 10.  Early Senescence and Leukocyte Telomere Shortening in SCHIZOPHRENIA: A Role for Cytomegalovirus Infection?

Authors:  Corona Solana; Diana Pereira; Raquel Tarazona
Journal:  Brain Sci       Date:  2018-10-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.